NORDIC BIO SYNDICATE INVESTMENT AS

Operating

Å erverve aksjer i selskapet Nordovo Biosciences AS (org. nr. 921331 312) samt bistå nevnte selskap med lån og andre finansielle instrumenter.

Gi lån til, investere i og administrere investering i bioteknologiselskapet Nordovo Biosciences AS.

Organization

Chairman of the board: JO
Jan Olav Øksnes1986
Years since formation: 5 years; since Dec 3, 2020
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 60,000; 1 share class
Total number of shareholders: 7; 5 companies, 2 persons

Financials

Annual total result 2024: -4,217; NOK
Total equity 2024: 820,982; NOK

Last update: Sep 9, 2025

Management

Board

Name	Role	Shares
JO Jan Olav Øksnes 1986	Chairman	11.7 % indirectly

Top 10 individual shareholders

Name	Role	Shares
ES Espen Stenersen 1984	-	31.91 % directly
LM Lotte Maria Beate Skolem 1986	-	12.77 % directly
JO Jan Olav Øksnes 1986	Chairman	11.7 % indirectly
HV Hans Vidar Hanssen 1971	-	10.64 % indirectly
TS Tor Sverre Bjørnæs 1947	-	9.04 % indirectly
JØ Jo Ørjasæter 1987	-	7.45 % indirectly
JT Jan Tveterås 1989	-	7.45 % indirectly
CB Christian Bjørnæs 1972	-	3.02 % indirectly
NM Nicolai Maric Bjørnæs 1985	-	3.02 % indirectly
JB Janne Bjørnæs 1975	-	3 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
ES Espen Stenersen 1984	Ordinary shares	19,148	31.91 %
L LEADENHALL INVEST AS	Ordinary shares	10,852	18.09 %
LM Lotte Maria Beate Skolem 1986	Ordinary shares	7,660	12.77 %
R RETT ØST INVEST AS	Ordinary shares	7,022	11.7 %
C CHRISTIANIA DECO AS	Ordinary shares	6,382	10.64 %
B B-YARD HOLDING AS	Ordinary shares	4,468	7.45 %
A AXIOM INVEST AS	Ordinary shares	4,468	7.45 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2020
Total operating income	0	0	0	0
Annual Total Result	-4,217	-5,758	-20,100	-3,101
Total assets	3,909,644	2,014,860	2,020,618	854,156
Total liabilities	3,088,662	1,189,662	1,189,662	827,257
Total equity	820,982	825,198	830,956	26,899

P&L

Year	2024	2023	2022	2020
Total operating income	0	0	0	0
Total operating costs	4,217	5,758	20,100	3,101
Operating result	-4,217	-5,758	-20,100	-3,101
Financial income/costs	0	0	0	0
Profit before tax	-4,217	-5,758	-20,100	-3,101
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-4,217	-5,758	-20,100	-3,101

Balance overview

Year	2024	2023	2022	2020
Total fixed assets	0	0	2,012,157	854,157
Total current assets	3,909,644	2,014,860	8,461	-1
Total assets	3,909,644	2,014,860	2,020,618	854,156
Short term debt	947,000	0	0	3,100
Long term debt	2,141,662	1,189,662	1,189,662	824,157
Total liabilities	3,088,662	1,189,662	1,189,662	827,257
Contributed capital	820,982	825,198	854,157	30,000
Retained earnings	0	0	-23,201	-3,101
Total equity	820,982	825,198	830,956	26,899
Total equity and liabilities	3,909,644	2,014,860	2,020,618	854,156

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

NORDIC BIO SYNDICATE INVESTMENT AS925 994 278